Burkholderia cenocepacia induces neutrophil necrosis in chronic granulomatous disease
Related Experiment Video
Updated: Aug 19, 2026

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay
Published on: May 12, 2023
Johan Bylund1, Paul A Campsall, Rebecca C Ma
1Department of Pediatrics, University of British Columbia, British Columbia Research Institute for Children's and Women's Health, Vancouver, British Columbia, Canada.
Insights
Burkholderia cenocepacia causes apoptosis in normal neutrophils but necrosis in chronic granulomatous disease (CGD) neutrophils. This difference in cell death may explain the extreme virulence of B. cepacia complex in CGD patients.
Area of Science:
- Immunology
- Microbiology
- Pathogenesis
Background:
- The Burkholderia cepacia complex poses a severe threat to patients with chronic granulomatous disease (CGD).
- CGD patients have phagocytes that cannot produce reactive oxygen species (ROS), impairing their ability to fight infections.
- B. cepacia complex is exceptionally virulent in CGD, leading to septicemia and high mortality rates.
Purpose of the Study:
- To investigate the interaction between Burkholderia cenocepacia and human neutrophils, particularly in the context of CGD.
- To elucidate the mechanisms underlying the heightened virulence of B. cepacia complex in CGD patients.
Main Methods:
- Phagocytosis assays using normal human neutrophils and neutrophils from CGD patients.
- Assessment of neutrophil apoptosis and necrosis following bacterial challenge.
- Investigation of the role of ROS and bacterial viability in the observed cellular responses.
Main Results:
- B. cenocepacia was readily ingested by normal neutrophils, inducing apoptosis independent of ROS.
- Neutrophils from CGD patients underwent apoptosis to a similar extent as normal neutrophils.
- Crucially, B. cenocepacia induced necrosis in CGD neutrophils, but not in normal neutrophils.
Conclusions:
- The pro-necrotic effect of B. cenocepacia on CGD neutrophils, occurring in the absence of ROS, may be responsible for its extreme virulence in these patients.
- Bacterial viability is essential for the pro-apoptotic and pro-necrotic effects.
- Understanding these mechanisms could inform therapeutic strategies for CGD patients infected with B. cepacia complex.
Abstract:
Burkholderia cepacia complex is a life-threatening group of pathogens for patients with chronic granulomatous disease (CGD), whose phagocytes are unable to produce reactive oxygen species (ROS). Unlike other CGD pathogens, B. cepacia complex is particularly virulent, characteristically causing septicemia, and is the bacterial species responsible for most fatalities in these patients. We found that a nonmucoid Burkholderia cenocepacia (a predominant species in the B. cepacia complex) isolate was readily ingested by normal human neutrophils under nonopsonic conditions and promoted apoptosis in these cells. The proapoptotic effect was not due to secreted bacterial products, but was dependent on bacterial viability. Phagocytosis was associated with a robust production of ROS, and the apoptotic neutrophils could be effectively cleared by monocyte-derived macrophages. The proapoptotic effect of B. cenocepacia was independent of ROS production because neutrophils from CGD patients were rendered apoptotic to a similar degree as control cells after challenge. More importantly, neutrophils from CGD patients, but not from normal individuals, were rendered necrotic after phagocytosis of B. cenocepacia. The extreme virulence of B. cepacia complex bacteria in CGD, but not in immunocompetent hosts, could be due to its necrotic potential in the absence of ROS.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
Cryptococcal Meningitis
Inhalation Anthrax
Bacterial Meningitis II: Pathophysiology
Differentiation of Common Myeloid Progenitor Cells

